PMID: 7540653Jul 1, 1995Paper

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

The Journal of Experimental Medicine
A Porgador, E Gilboa

Abstract

It has previously been shown that bone marrow-generated dendritic cells (DC) are potent stimulators in allogeneic mixed leukocyte reactions and are capable of activating naive CD4+ T cells in situ in an antigen-specific manner. In this study we have investigated whether bone marrow-generated DC are capable of inducing antigen-specific CD8+ T cell responses in vivo. Initial attempts to induce specific cytotoxic T lymphocyte (CTL) responses in mice injected with bone marrow-generated DC pulsed with ovalbumin (OVA) peptide were frustrated by the presence of high levels of nonspecific lytic activity, which obscured, though not completely, the presence of Ag-specific CTL. Using conditions that effectively differentiate between antigen-specific and nonspecific lytic activity, we have shown that bone marrow-generated DC pulsed with OVA peptide are potent inducers of OVA-specific CTL responses in vivo, compared with splenocytes or RMA-S cells pulsed with OVA peptide, or compared with immunization with free OVA peptide mixed with adjuvant. Antibody-mediated depletion experiments have shown that the cytotoxic effector cells consist primarily of CD8+ cells, and that induction of CTL in vivo is dependent on CD4+ as well as on CD8+ T cells....Continue Reading

References

Nov 1, 1979·The Journal of Experimental Medicine·H von Boehmer, W Haas
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·R M Steinman, M D Witmer
Mar 1, 1978·The Journal of Experimental Medicine·R M ZinkernagelJ Klein
Aug 1, 1992·The Journal of Experimental Medicine·S Guerder, P Matzinger
Nov 1, 1991·European Journal of Immunology·O RötzschkeH G Rammensee
Jan 1, 1991·Annual Review of Immunology·R M Steinman
Apr 1, 1990·The Journal of Experimental Medicine·J W Young, R M Steinman
Jun 1, 1988·The Journal of Experimental Medicine·F R CarboneM J Bevan
Apr 1, 1989·The Journal of Experimental Medicine·S E MacatoniaB A Askonas
Apr 21, 1989·Journal of Immunological Methods·T VolgmannH Mohr
Jul 1, 1987·The Journal of Experimental Medicine·K InabaR M Steinman
Jul 1, 1983·The Journal of Experimental Medicine·W C Van VoorhisR M Steinman
Mar 1, 1982·The Journal of Experimental Medicine·J A Keene, J Forman

❮ Previous
Next ❯

Citations

Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·K FurumotoM Imamura
Sep 1, 1996·Cancer Metastasis Reviews·R G Vile, H Chong
Jan 1, 2005·Indian Journal of Clinical Biochemistry : IJCB·D TomarD N Rao
Apr 20, 2005·Cancer Immunology, Immunotherapy : CII·Frank GrünebachPeter Brossart
Dec 17, 2008·Cancer Immunology, Immunotherapy : CII·Annabelle Grolleau-JuliusRaymond L Yung
Mar 16, 2006·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yalin RenAize Kijlstra
Oct 20, 2005·Journal of Neuro-oncology·Prachya VichchatornSuradej Hongeng
Aug 23, 2001·Journal of Immunological Methods·M J TurnerJ G Frelinger
Apr 6, 1999·Pharmacology & Therapeutics·B R MinevM S Mitchell
Sep 21, 2000·Immunology Letters·M Nouri-ShiraziK Palucka
Sep 21, 2000·Immunology Letters·L EisenbachK El-Shami
Nov 8, 2001·Experimental Hematology·P BrossartL Kanz
Dec 16, 1998·Research in Immunology·T LesimpleL Toujas
Oct 1, 1996·Current Opinion in Immunology·N P Restifo
May 7, 1997·Transfusion Science·J Banchereau
Nov 5, 2002·Critical Reviews in Oncology/hematology·A H KlimpT Daemen
Mar 24, 1999·Molecular Medicine Today·C A Colaco
Jun 1, 1997·Cytokine & Growth Factor Reviews·A MackensenR Mertelsmann
Nov 1, 1996·Immunotechnology : an International Journal of Immunological Engineering·M E RessingC J Melief
Oct 1, 1996·Nature Medicine·C CondonL D Falo
May 11, 2002·Nature Reviews. Immunology·Drew M Pardoll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.